Michael Steinmetz

Michael Steinmetz

No más puestos en curso
77 años
Health Technology
Finance
Consumer Services

Perfil

Dr. Michael Steinmetz is a Managing Director at Clarus Ventures LLC and a Managing Director at Clarus Lifesciences II LP.
He is on the Board of Directors at Lycera Corp., TaiGen Biopharmaceuticals Holdings Ltd., Oxford Immunotec, Inc., TaiGen Biotechnology Co., Ltd., ISB Accelerator Corp., PhysIOM LLC, CGI Pharmaceuticals, Inc., Viral Logic Systems Technology Corp., Oxford Immunotec Ltd., and Novimmune SA. Dr. Steinmetz was previously employed as Independent Director by VBI Vaccines, Inc., Independent Director by TetraLogic Pharmaceuticals Corp., Non-Executive Director by Heptares Therapeutics Ltd., Independent Director by MacroGenics, Inc., General Partner by MPM Capital LP, Head-Biotechnology by F.
Hoffmann-La Roche Ltd., a Principal by Basel Institute for Immunology, and a Principal by California Institute of Technology.
He also served on the board at Variation Biotechnologies, Allozyne, Inc., Oxford Immunotec Global Plc, Novimmune SA, Swedish Orphan Biovitrum AB, BioXell SpA, Biovitrum AB, ESBATech AG, Accelerator Corp., Acorda Therapeutics, Inc., Homestead Clinical Corp., Intracel Corp., Intracel Resources LLC, and Virdante Pharmaceuticals, Inc. He received his undergraduate degree from the University of Hamburg and a doctorate degree from Ludwig-Maximilians-Universität München.

Antiguos cargos conocidos de Michael Steinmetz.

EmpresasCargoFin
Corporate Officer/Principal 06/08/2016
Director/Miembro de la Junta 06/08/2016
Director/Miembro de la Junta 06/08/2016
Director/Miembro de la Junta 06/08/2016
Inversor de Capital Privado 06/08/2016
Ver el detalle de la experiencia de Michael Steinmetz.

Formación de Michael Steinmetz.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

74

Relaciones de 1er grado

35

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas35

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Finance

Health Technology

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Consumer Services

Finance

Health Technology

Finance

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Michael Steinmetz